This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
Addition/Correction Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX
pubs.acs.org/jmc
Correction to 6‑Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Downloaded via 185.14.192.134 on March 23, 2019 at 01:14:43 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Homan Chan, Brant Firestone, Michelle Fodor, Jorge Fortanet, Huaixiang Hao, Murphy Hentemann, Andriana Jouk, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Gang Liu, Shumei Liu, Chen Liu, Eric McNeill, Morvarid Mohseni, Michael D. Shultz, Martin Sendzik, Travis Stams, Stan Spence, Victoriano Tamez, Ritesh Tichkule, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, Bing Yu, and Matthew J. LaMarche* J. Med. Chem. 2019, 62 (4), 1793−1802. DOI: 10.1021/acs.jmedchem.8b01726 Page 1793. Michael D. Shultz† and Andriana Jouk† should be listed as additional coauthors, and the order of the authors are as listed above in the byline. † Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts, 02139, United States
© XXXX American Chemical Society
A
DOI: 10.1021/acs.jmedchem.9b00436 J. Med. Chem. XXXX, XXX, XXX−XXX